Últimas noticias sobre Jeffs Brands (NASDAQ:JFBR) Bolsa

Jeffs Brands

Jeffs Brands Ltd is an e-commerce CPG company, operating on Amazon. The company serves as the holding company of other e-commerce companies, Smart Repair Pro, Purex, and Top Rank, that operate online stores for the sale of various consumer products on Amazon online marketplace, utilizing the FBA model. The company has five wholly-owned subsidiaries: Smart Repair Pro, Purex, Top Rank , Fort and Jeffs' Brands Holdings. The company also utilizes internal methodologies to analyze sales data and patterns on Amazon in order to identify existing stores, niches and products that have the potential for development and growth, and for maximizing sales of existing proprietary products.

Jeffs Brands Ltd

Barclays analyst Richard Hightower initiates coverage on Agree Realty (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/ADC#NYSE">ADC</a>) with a Underweight rating and announces Price Target of $76.

News

Price Target

Initiation

Analyst Ratings

Barclays Initiates Coverage On Agree Realty with Underweight Rating, Announces Price Target of $76

The most oversold stocks in the financial sector presents an opportunity to buy into undervalued companies.
The RSI is a momentum indicator, which compares a stock&#8217;s strength on days when prices go up to its strength on days when prices go down. When compared to a stock&#8217;s price action, it can give traders a better sense of how a stock may perform in the short term. An asset is typically considered oversold when the <a href="https://www.benzinga.com/topic/rsi">RSI is below 30</a>, according to <a href="https://pro.benzinga.com/">Benzinga Pro</a>.
Here's the latest list of major oversold players in this sector, having an RSI near or below 30.
<h3 class="wp-block-heading">Horizon Technology Finance Corp (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/HRZN#NASDAQ">HRZN</a>)</h3>
<ul>
<li>On Oct. 29, Horizon Tech Finance posted downbeat quarterly results. &#8220;We had a solid third quarter, as we originated a number of new, high-quality loans that returned our portfolio to quarter-over-quarter growth, while we saw the venture debt market begin to improve,&#8221; said Robert D. Pomeroy, Jr., Chairman and Chief Executive Officer of Horizon. The company's stock fell around 9% over the past five days and has a <a href="https://www.benzinga.com/quote/INSW">52-week low of $8.50</a>.</li>
<li>RSI Value: 14.14&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;</li>
<li>HRZN Price Action: Shares of Horizon Technology Finance fell 6.6% to close at $8.57 on Monday.</li>
<li>Benzinga Pro's real-time newsfeed alerted to<a href="https://bzresearch.myclickfunnels.com/benzinga-pro-content-webinar-registration/?utm_source=BZprocontent121724&amp;t=be2bearmibe3na1"> latest HRZN new</a>s. </li>
</ul>
<figure class="wp-block-image size-full is-resized"><a href="https://bzresearch.myclickfunnels.com/benzinga-pro-content-webinar-registration/?utm_source=BZprocontent121724&amp;t=be2bearmibe3na1"><img loading="lazy" decoding="async" width="905" height="842" src="https://editorial-assets.benzinga.com/wp-content/uploads/2024/12/17031412/image-137.png" alt="" class="wp-image-695319" style="width:593px;height:auto" srcset="https://editorial-assets.benzinga.com/wp-content/uploads/2024/12/17031412/image-137.png 905w,https://editorial-assets.benzinga.com/wp-content/uploads/2024/12/17031412/image-137-300x279.png 300w,https://editorial-assets.benzinga.com/wp-content/uploads/2024/12/17031412/image-137-768x715.png 768w" sizes="(max-width: 905px) 100vw, 905px" /></a></figure>
<h3 class="wp-block-heading">Pennantpark Floating Rate Capital Ltd (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/PFLT#NYSE">PFLT</a>)&nbsp;</h3>
<ul>
<li>On Dec. 12, PennantPark Floating Rate Capital announced upsize of joint venture. PFLT and its JV partner jointly agreed to invest an additional $100m of capital in PSSL. The company's stock fell around 3% over the past five days and <a href="https://www.benzinga.com/quote/PFLT">has a 52-week low</a> of $10.28.</li>
<li>RSI Value: 28.02</li>
<li>PFLT Price Action: Shares of Pennantpark Floating Rate Capital fell 1% to close at $10.81 on Monday.</li>
<li>Benzinga Pro&#8217;s charting tool helped identify the<a href="https://bzresearch.myclickfunnels.com/benzinga-pro-content-webinar-registration/?utm_source=BZprocontent121724&amp;t=be2bearmibe3na1"> trend in PFLT stock</a>. </li>
</ul>
<figure class="wp-block-image size-full is-resized"><a href="https://bzresearch.myclickfunnels.com/benzinga-pro-content-webinar-registration/?utm_source=BZprocontent121724&amp;t=be2bearmibe3na1"><img loading="lazy" decoding="async" width="912" height="847" src="https://editorial-assets.benzinga.com/wp-content/uploads/2024/12/17031458/image-138.png" alt="" class="wp-image-695320" style="width:604px;height:auto" srcset="https://editorial-assets.benzinga.com/wp-content/uploads/2024/12/17031458/image-138.png 912w,https://editorial-assets.benzinga.com/wp-content/uploads/2024/12/17031458/image-138-300x279.png 300w,https://editorial-assets.benzinga.com/wp-content/uploads/2024/12/17031458/image-138-768x713.png 768w" sizes="(max-width: 912px) 100vw, 912px" /></a></figure>
Principal Financial Group Inc (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/PFG#NASDAQ">PFG</a>)
<ul>
<li>On Dec. 11, Wells Fargo analyst Elyse Greenspan downgraded Principal Finl from Equal-Weight to Underweight and lowered the price target from $84 to $75. The company's stock fell around 9% over the past month and has a 52-week <a href="https://www.benzinga.com/quote/PFG">low of $72.21.</a></li>
<li>RSI Value: 26.47</li>
<li>PFG Price Action: Shares of Principal Financial fell 0.3% to close at $78.67 on Monday.</li>
<li>Benzinga Pro&#8217;s signals feature notified of a potential <a href="https://bzresearch.myclickfunnels.com/benzinga-pro-content-webinar-registration/?utm_source=BZprocontent121724&amp;t=be2bearmibe3na1">breakout in PFG shares</a>. </li>
</ul>
<figure class="wp-block-image size-full is-resized"><a href="https://bzresearch.myclickfunnels.com/benzinga-pro-content-webinar-registration/?utm_source=BZprocontent121724&amp;t=be2bearmibe3na1"><img loading="lazy" decoding="async" width="908" height="845" src="https://editorial-assets.benzinga.com/wp-content/uploads/2024/12/17031555/image-139.png" alt="" class="wp-image-695322" style="width:624px;height:auto" srcset="https://editorial-assets.benzinga.com/wp-content/uploads/2024/12/17031555/image-139.png 908w,https://editorial-assets.benzinga.com/wp-content/uploads/2024/12/17031555/image-139-300x279.png 300w,https://editorial-assets.benzinga.com/wp-content/uploads/2024/12/17031555/image-139-768x715.png 768w" sizes="(max-width: 908px) 100vw, 908px" /></a></figure>
Read This Next: 
<ul>
<li><a href="https://www.benzinga.com/news/earnings/24/12/42507875/how-to-earn-500-a-month-from-worthington-enterprises-stock-ahead-of-q2-earnings">How To Earn $500 A Month From Worthington Enterprises Stock Ahead Of Q2 Earnings</a></li>
</ul>

Long Ideas

Pre-Market Outlook

Markets

Trading Ideas

HRZN

PFLT

Top 3 Financial Stocks Which Could Rescue Your Portfolio For December

Initial $5 million investment for common stock priced at an average of $0.96 per share; Up to an additional $14 million may be raised from exercise of warrants
Albert L. Lord, Thomas J. Kozlowski Jr., and Calvin D. Walsh added to the Board of Directors

APCX

AppTech Welcomes $5M Investment from AFIOS Partners, Restructures Board With Three New Directors

Barclays analyst Rich Hightower assumes W.P. Carey (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/WPC#NYSE">WPC</a>) with a Underweight rating and raises Price Target to $59.

Barclays Assumes W.P. Carey at Underweight, Raises Price Target to $59

Rockwell Medical, Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/RMTI#NASDAQ">RMTI</a>) shares are trading higher premarket on Tuesday after it entered into a product purchase agreement with a <a target="_blank" href="https://www.benzinga.com/pressreleases/24/12/b42525272/rockwell-medical-enters-into-a-multi-year-product-purchase-agreement-with-the-worlds-leading-provi" rel="noreferrer noopener">provider of dialysis products and services</a>.
As per the three-year agreement, Rockwell Medical will supply its SteriLyte liquid bicarbonate product to the customer, with an option to renew it for two additional one-year terms.
The agreement is expected to generate over $10 million in net sales in the first year, a portion of which was not included in Rockwell Medical&#8217;s previously announced revenue estimates for 2025, with incremental price increases in subsequent years.
Last week, the company announced the promotion of Jesse Neri to the <a target="_blank" href="https://www.benzinga.com/pressreleases/24/12/b42456143/rockwell-medical-promotes-jesse-neri-to-chief-financial-officer" rel="noreferrer noopener">post of Chief Financial Officer</a>.
This month, Rockwell Medical disclosed a partnership with HydroCare in which HydroCare will purchase and install Rockwell&#8217;s DAMX45 dry acid concentrate <a target="_blank" href="https://www.benzinga.com/pressreleases/24/12/b42334338/rockwell-medical-partners-with-hydrocare-to-distribute-and-install-its-dry-acid-concentrate-mix-sy" rel="noreferrer noopener">mix system in dialysis water rooms</a>.
This installation is expected to drive new sales for Rockwell&#8217;s dry acid hemodialysis concentrates.
Also, last month, the company inked a distribution deal with <a target="_blank" href="https://www.benzinga.com/pressreleases/24/11/b42057509/rockwell-medical-expands-distribution-in-the-philippines" rel="noreferrer noopener">Nephro Group Dialysis Centers</a>.
Price Action: RMTI shares are up 14.4% at $2.29 premarket at the last check Tuesday.
Read Next:
<ul>
<li><a href="https://www.benzinga.com//node/42526136" target="_blank" rel="noreferrer noopener">Asia Mostly Lower, Europe Markets Up As Dollar Strengthens Ahead Of Fed Rate Decision &#8211; Global Markets Today While US Slept</a></li>
</ul>
Image via Shutterstock.

Equities

Contracts

Small Cap

Movers

RMTI

Rockwell Medical Scores Multi-Year Dialysis Deal; Stock Jumps

Top Wall Street analysts changed their outlook on these top names. For a complete view of all analyst rating changes, including upgrades and downgrades, please see our <a href="https://www.benzinga.com/analyst-stock-ratings">analyst ratings page</a>.
<ul>
<li>Roth MKM analyst Justin Clare initiated coverage on Atkore Inc. (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/ATKR#NYSE">ATKR</a>) with a Buy rating and announced a price target of $100. Atkore shares closed at $84.61 on Monday. See how other analysts view this stock.</li>
<li>Piper Sandler analyst Patrick Moley initiated coverage on Riot Platforms, Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/RIOT#NASDAQ">RIOT</a>) with an Overweight rating and announced a price target of $23. Riot Platforms shares closed at $14.03 on Monday. <a href="https://www.benzinga.com/quote/RIOT/analyst-ratings">See how other analysts view this stock</a>.</li>
<li>Deutsche Bank analyst Andrew Krill initiated coverage on Watts Water Technologies, Inc. (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/WTS#NYSE">WTS</a>) with a Hold rating and announced a price target of $240. Watts Water Technologies shares closed at $218.67 on Monday. <a href="https://www.benzinga.com/quote/WTS/analyst-ratings">See how other analysts view this stock</a>.</li>
<li>Morgan Stanley analyst Sanjit Singh initiated coverage on Elastic N.V. (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/ESTC#NYSE">ESTC</a>) with an Overweight rating and announced a price target of $130. Elastic shares closed at $104.61 on Monday. See how other analysts view this stock.</li>
<li>Oppenheimer analyst Steve Lichtman initiated coverage on Penumbra, Inc. (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/PEN#NYSE">PEN</a>) with an Outperform rating and announced a price target of $275. Penumbra shares closed at $247.24 on Monday. <a href="https://www.benzinga.com/quote/PEN/analyst-ratings">See how other analysts view this stock.</a></li>
</ul>
Considering buying ESTC stock? Here&#8217;s what analysts think: 
<figure class="wp-block-image size-large is-resized"><img loading="lazy" decoding="async" width="1024" height="594" src="https://editorial-assets.benzinga.com/wp-content/uploads/2024/12/17074936/image-146-1024x594.png" alt="" class="wp-image-695669" style="width:590px;height:auto" srcset="https://editorial-assets.benzinga.com/wp-content/uploads/2024/12/17074936/image-146-1024x594.png 1024w,https://editorial-assets.benzinga.com/wp-content/uploads/2024/12/17074936/image-146-300x174.png 300w,https://editorial-assets.benzinga.com/wp-content/uploads/2024/12/17074936/image-146-768x446.png 768w,https://editorial-assets.benzinga.com/wp-content/uploads/2024/12/17074936/image-146.png 1098w" sizes="(max-width: 1024px) 100vw, 1024px" /></figure>
Read This Next: 
<ul>
<li><a href="https://www.benzinga.com/news/earnings/24/12/42507875/how-to-earn-500-a-month-from-worthington-enterprises-stock-ahead-of-q2-earnings">Jabil Gears Up For Q1 Print; Here Are The Recent Forecast Changes From Wall Street&#8217;s Most Accurate Analysts</a></li>
</ul>

ATKR

ESTC

RIOT

This Elastic Analyst Begins Coverage On A Bullish Note; Here Are Top 5 Initiations For Tuesday

JP Morgan analyst Lisa Gill downgrades PACS Group (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/PACS#NYSE">PACS</a>) from Overweight to Neutral and announces $18 price target.

Downgrades

PACS

JP Morgan Downgrades PACS Group to Neutral, Announces $18 Price Target

Looking Ahead to 2025
In 2025, our key priorities include:
<ul>
<li>Advancing ViraxImmune&#x2122; UK and U.S. Clinical Validation Studies: We will be leveraging insights gained from ongoing data and collaborations to fine-tune our offerings for broad-scale deployment. We expect to present key data at major international scientific conferences.</li>
<li>U.S. regulatory Progress: We aim to initiate formal interactions with regulatory authorities to define the approval pathway for the ViraxImmune&#x2122; IVD platform. This step is critical to transitioning our innovative assays into clinical use.</li>
<li>Expansion of ImmuneSelect Distribution Channels: Building on recent agreements, we will focus on growing our presence in additional markets, with particular emphasis on the Americas, and into U.S.-based markets.</li>
<li>Initiation of Protective Immunity IVD clinical performance study (Lyme Disease and Pre &amp; Post Transplant Infection).</li>
</ul>
This multi-faceted approach underscores our commitment to innovation, market growth, and scientific excellence as we position Virax as a leader in immune diagnostic solutions.
Financial Highlights
Research and development activities have accelerated from the prior year in both capital expenditures and research expenses. We have tripled our laboratory area since signing our first lease in BioCity, Glasgow in August 2023 and doubled our property, plant and equipment for that lab to approximately $1.1 million as of September 30, 2024 from the prior period.&nbsp; Our ongoing research and development expenses were approximately 33% higher year over year as of September 30, 2024.
During 2024, we received approximately $0.8 million from a warrant exercise and approximately $5.1 million from two cash for stock transactions, each in increasing valuation per raise.&nbsp;Our cash balance as of September 30, 2024 was approximately $7.3 million and working capital was approximately $6.6 million.&nbsp;In addition, we do not have any long-term debt obligations. Regarding the stock valuation, as of December 10, 2024, our&nbsp;shares are trading at a price&nbsp;less than&nbsp;our current cash on hand per share. &nbsp;We&nbsp;believe&nbsp;this valuation&nbsp;is not representative of the overall value&nbsp;and future potential&nbsp;of Virax. With the current cash balance and no debt to service, we believe we have adequate capital to fund our near-term priorities.

VRAX

Virax Biolabs Announces 2025 Strategic Priorities, Highlighting Clinical Validation For Viraximmune And Global Expansion of ImmuneSelect

JP Morgan analyst Lisa Gill downgrades InnovAge Holding (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/INNV#NASDAQ">INNV</a>) from Neutral to Underweight and announces $5 price target.

INNV

JP Morgan Downgrades InnovAge Holding to Underweight, Announces $5 Price Target

The district's new wired and wireless network enhances digital learning environment for students and staff, helps drive academic success

JNPR

Juniper Networks Powers Digital Learning For Port Huron Schools With AI-Driven Network Modernization

WIIM

VIAV

Viavi Solutions shares are trading lower after Morgan Stanley downgraded the stock from Equal-Weight to Underweight, despite raising its price target from $8 to $9.50.

ESTA

Elastic shares are trading higher after Morgan Stanley initiated coverage on the stock with an Overweight rating and a price target of $130.

Northland Capital Markets analyst Robert Brooks maintains RealReal (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/REAL#NASDAQ">REAL</a>) with a Outperform and raises the price target from $6.5 to $12.5.

REAL

Northland Capital Markets Maintains Outperform on RealReal, Raises Price Target to $12.5

JP Morgan analyst Benjamin Rossi assumes Tenet Healthcare (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/THC#NYSE">THC</a>) with a Overweight rating and announces Price Target of $175.

JP Morgan Assumes Tenet Healthcare at Overweight, Announces Price Target of $175

Cloudflare shares are trading higher after Stifel upgraded the stock from Hold to Buy and raised its price target from $95 to $136.

TSLA

Tesla shares are trading higher after Mizuho upgraded the stock from Neutral to Outperform and raised its price target from $230 to $515.

Albertsons Companies shares are trading higher after Telsey Advisory Group upgraded the stock from Market Perform to Outperform and raised its price target from $21 to $26.

Order Follows Successful Trials and is the Hyzon's Second Fuel Cell Refuse Vehicle Order

HYZN

Hyzon Secures Order For Hydrogen Fuel Cell Trucks From South San Francisco Scavenger Company After Successful Trials

Pfizer shares are trading higher after the company issued its 2025 outlook.

Susquehanna analyst James Friedman initiates coverage on Globant (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/GLOB#NYSE">GLOB</a>) with a Positive rating and announces Price Target of $255.

GLOB

Susquehanna Initiates Coverage On Globant with Positive Rating, Announces Price Target of $255

Jeffs' Brands (JFBR) has entered into a binding Letter of Intent with Deliverz.AI. The LOI, entered into on November 27, 2024, outlines a plan to e...

Jeffs' Brands, Deliverz.AI sign binding LOI for U.S. joint venture

Jeffs' Brands Ltd. (JFBR) has released an update. Jeffs' Brands Ltd. has reported an impressive 83% increase in sales during November 2024, reachin...

Jeffs' Brands Celebrates Record-Breaking Amazon Sales

Jeffs' Brands (JFBR) entered into an agreement granting it the exclusive worldwide right to distribute certain advanced drone safety systems develo...

Jeffs' Brands secures distribution rights to sell drone safety systems

Jeffs' Brands Ltd. (JFBR) has released an update. Jeffs' Brands Ltd has secured exclusive worldwide rights to distribute advanced drone safety syst...

Jeffs' Brands Gains Exclusive Drone System Distribution Rights

Jeffs' Brands regains compliance with Nasdaq minimum bid price rule

Jeffs' Brands (JFBR) announced that it has received a written notice from Nasdaq, indicating that the company has regained compliance with the mini...

Jeffs' Brands regains compliance with Nasdaq

Jeffs' Brands Ltd. (JFBR) has released an update. Jeffs' Brands Ltd. has successfully regained compliance with Nasdaq's minimum bid price rule as i...

Jeffs' Brands Secures Nasdaq Compliance, Boosts Investor Confidence

Jeffs' Brands (JFBR), a data-driven e-commerce company operating on the Amazon (AMZN) Marketplace, announced that it has entered into an agreement ...

Jeffs' Brands wins global exclusive for drone system distribution on Amazon

Jeffs' Brands files to sell 2.34M ordinary shares for holders

17:20 EST Jeffs' Brands (JFBR) files to sell 2.34M ordinary shares for holders Published first on TheFly – the ultimate source for real-time, marke...

AMZN

JFBR

Press Releases

Jeffs' Brands: Fort (100%) Seeks to Revolutionizes E-Commerce with AI-Based Pest Control App and Bitcoin Payment Integration

Jeffs' Brands and Deliverz.AI Sign a Binding Letter of Intent for a U.S. Joint Venture Involving AI-Powered Fully Autonomous Robots

Jeffs' Brands Announces Trademark Registration Approval for Wellution®, a Wellness and Personal Care Brand (49%) from the USPTO

Jeffs' Brands: Fort Achieves Record-Breaking Sales of $1.2 Million from its Amazon Platform During Black Friday and the November 2024 Shopping Season

Global Medical Service Robotics Market Project to Exceed $20 Billion in 2024 with Additional Growth Expected

Jeffs' Brands Secures Exclusive Worldwide Distribution Rights to Sell Drone Safety Systems on Amazon

Jeffs' Brands Regains Compliance with Nasdaq Minimum Bid Price Rule

"Cardiol Therapeutics (NASDAQ: CRDL) Heart Health Innovation – AVCO, GXAI, UPC, and More Stocks Driving Groundbreaking Advances"

Jeffs' Brands Wins Global Exclusive for Drone System Distribution on Amazon

AVCO

CRDL

GILD

GXAI

JFBRW

MBOT

SERV

ZBAO

Baozun

1stdibs.com

Groupon

Hour Loop

Jumia Technologies AG American Depositary Shares, each representing two Ordinary Shares

Jumia Technologies

Linkage Global Inc - Class A Ordinary Shares

Linkage Global

LightInTheBox Holding Co., Ltd. American Depositary Shares, each representing twelve ordinary shares

LightInTheBox Holding

ContextLogic

MOGU Inc. American Depositary Shares (each representing 25 Class A Ordinary Shares)

Comments

Jeffs Brands

Noticias

Últimas noticias sobre Jeffs Brands (NASDAQ:JFBR) Bolsa

La gente también mira

Noticias

SOCIO/CONTRIBUIDOR

BENZINGA GLOBAL